TAK-279-3002, NCT06108544: A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period |
|
|
| Recruiting | 3 | 1000 | Europe, Canada, US | TAK-279, Placebo, Apremilast | Takeda | Plaque Psoriasis | 07/25 | 06/26 | | |
| Not yet recruiting | N/A | 20 | US | Metronidazole cream, Cetaphil moisturizer, CeraVe moisturizer, Eucerin Healing Lotion moisturizer, Aveeno Calm and Restore Oat Gel moisturizer | Duke University, National Rosacea Society | Rosacea, Erythematotelangiectatic | 12/25 | 12/25 | | |
